Showing 1 - 3 results of 3 for search 'JT Merrill', query time: 0.02s
Refine Results
-
1
PO.6.132 A phase 2b study of afimetoran (BMS-986256) in patients with active systemic lupus erythematosus (SLE): optimization of a lupus clinical trial design by S Banerjee, V Shah, M Harrison, Y Shen, JT Merrill, U Ranganathan, MK Crow, N Delev, D Grasela, E Culotta, S Greenberg
Published 2022-10-01Article -
2
S11.2 Efficacy and safety of deucravacitinib, a selective TYK2 inhibitor, in patients with active systemic lupus erythematosus: results from a phase 2, randomized, double-blind, pl... by S Banerjee, S Singhal, V Shah, R Van Vollenhoven, M Pike, E Morand, I Catlett, VP Werth, JT Merrill, N Delev, C Hobar, B Sharkey, T Wegman
Published 2022-10-01Article -
3
S15.2 Severe non-adherence to hydroxychloroquine is associated with flares, early damage, and mortality in systemic lupus erythematosus: data from 660 patients from the slicc incep... by C Gordon, A Rahman, M Inanc, M Petri, DA Isenberg, S Jacobsen, S Bae, RF van Vollenhoven, S Lin, S Manzi, R Ramsey-Goldman, N Costedoat-Chalumeau, S Bernatsky, J Sanchez-Guerrero, C Aranow, G Ruiz-Irastorza, M MacKay, EM Ginzler, DD Gladman, MA Dooley, A Askanase, Y Nguyen, A Jönsen, IN Bruce, DJ Wallace, JG Hanly, J Buyon, JT Merrill, B Blanchet, MB Urowitz, J Romero-Dia, AE Clarke, PR Fortin, GS Alarcón, V Le Gurn, KC Kalunian, CA Peschken, DL Kamen
Published 2022-10-01Article